Intratracheal Budesonide/Surfactant for Preventing Bronchopulmonary Dysplasia Reply

被引:0
|
作者
Yeh, Tsu F. [1 ]
Chen, Chung M. [1 ]
机构
[1] Taipei Med Univ, Taipei, Taiwan
关键词
D O I
10.1164/rccm.201603-0587LE
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:123 / 124
页数:2
相关论文
共 50 条
  • [21] Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial
    Francis, Kate L.
    McKinlay, Christopher J. D.
    Kamlin, C. Omar F.
    Cheong, Jeanie L. Y.
    Dargaville, Peter A.
    Dawson, Jennifer A.
    Doyle, Lex W.
    Jacobs, Susan E.
    Davis, Peter G.
    Donath, Susan M.
    Manley, Brett J.
    [J]. TRIALS, 2023, 24 (01)
  • [22] Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial
    Kate L Francis
    Christopher J D McKinlay
    C Omar F Kamlin
    Jeanie L Y Cheong
    Peter A Dargaville
    Jennifer A Dawson
    Lex W Doyle
    Susan E Jacobs
    Peter G Davis
    Susan M Donath
    Brett J Manley
    [J]. Trials, 24
  • [23] Strategies for preventing bronchopulmonary dysplasia
    Van Marter, LJ
    [J]. CURRENT OPINION IN PEDIATRICS, 2005, 17 (02) : 174 - 180
  • [24] Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia
    Bassler, Dirk
    Plavka, Richard
    Shinwell, Eric S.
    Hallman, Mikko
    Jarreau, Pierre-Henri
    Carnielli, Virgilio
    Van den Anker, Johannes N.
    Meisner, Christoph
    Engel, Corinna
    Schwab, Matthias
    Halliday, Henry L.
    Poets, Christian F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (16): : 1497 - 1506
  • [25] BRONCHOPULMONARY DYSPLASIA - REPLY
    SMYTH, JA
    LEVISON, H
    [J]. PEDIATRICS, 1982, 69 (03) : 387 - 388
  • [26] The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial
    Marzban, Asghar
    Mokhtari, Samira
    Tavakkolian, Pouria
    Mansouri, Reza
    Jafari, Nahid
    Maleki, Azam
    [J]. BMC PEDIATRICS, 2024, 24 (01)
  • [27] Review shows that using surfactant a number of times or as a vehicle for budesonide may reduce the risk of bronchopulmonary dysplasia
    Hascoet, Jm
    Picaud, Jc
    Ligi, I.
    Blanc, T.
    Daoud, P.
    Zupan, V.
    Moreau, F.
    Guilhoto, I.
    Rouabah, M.
    Alexandre, C.
    Saliba, E.
    Storme, L.
    Patkai, J.
    Pomedio, M.
    Hamon, I.
    [J]. ACTA PAEDIATRICA, 2018, 107 (07) : 1140 - 1144
  • [28] Use of budesonide associated with a pulmonary surfactant to prevent bronchopulmonary dysplasia in premature newborns- A systematic review
    Arruda Moraes, Lucas Hirano
    Dias Coelho, Rachel Mocelin
    Neves dos Santos Beozzo, Glenda Priscila
    Monteiro Yoshida, Renata de Araujo
    de Albuquerque Diniz, Edna Maria
    de Carvalho, Werther Brunow
    [J]. JORNAL DE PEDIATRIA, 2023, 99 (02) : 105 - 111
  • [29] METAANALYSES OF SURFACTANT AND BRONCHOPULMONARY DYSPLASIA REVISITED
    EGBERTS, J
    DEWINTER, JP
    [J]. LANCET, 1994, 344 (8926): : 882 - 882
  • [30] Definition of bronchopulmonary dysplasia -: Reply
    Lefebvre, F
    Grégoire, MC
    Glorieux, J
    [J]. PEDIATRICS, 1999, 103 (02) : 533 - 534